References
- Owens RC, Jr, Ambrose PG. Antimicrobal safety: Focus on fluoroquinolones. Clin Infect Dis Suppl 2005; 41: S144–S157
- Kelly WN, Arellano FM, Barnes J, Bergman U, et al. Guidelines for submitting adverse event report for publication. Drug Saf 2007; 30: 367–373
- George JN. Thrombotic thrombocytopenic purpura. N Eng J Med 2006; 354: 1927–1935
- Aster RH, Bougie DW. Drug-induced immune thrombocytopenia. N Eng J Med 2007; 357: 580–587
- Norton A, Roberts I. Management of Evans syndrome. Br J Haematol 2005; 132: 125–137
- Murrin RJA, Murray JA. Thrombotic thrombocytopenic purpura: Aetiology, pathophysiology and treatment. Blood Rev 2006; 29: 51–60
- Aird WC. Sepsis and coagulation. Crit Care Clin 2005; 21: 417–431
- Gales BJ, Sulak LB. Severe thrombocytopenia associated with alatrofloxacin. Ann Pharmacotherapy 2000; 34: 330–334
- Chichmanian RM, Spreux A, Bernard E, Garraffo R, et al. Thrombocytopenia due to pefloxacin: Dose dependent toxicity?. Therapie 1992; 47: 419–421
- Wensing JW, Vlasveld LT. Immune thrombocytopenia attributed to norfloxacin. Ned Tijdschr Geneeskd 1997; 23: 1660–1662
- Oh YR, Carr-Lopez SM, Probasco JM, Crawley PG. Levofloxacin-induced autoimmune haemolytic anaemia. Ann Pharmacother 2003; 37: 1010–1013
- Maguire RB, Stroncek DF, Gale E, Yearlsey M. Haemolytic anemia and acute renal failure associated with temafloxacin-dependent antibodies. Am J Hematol 1994; 46: 363–366
- Dutta TK, Badhe BA. Ciprofloxacin-induced bone-marrow depression. Postgrad Med J 1999; 75: 571–573
- McKay AD, Mehta A. Autoimmune haemolytic anaemia associated with ciprofloxacin. Clin Lab Haematol 1995; 17: 97–98
- Andrews PA, Robinson GT. Intravascular haemolysis and interstitial nephritis in association with ciprofloxacin. Nephron 1999; 83: 359–360
- Teh C, McKendrick M. Ciprofloxacin-induced thrombocytopenia. J Infect 1993; 27: 213–215
- Aydogdu I, Ozerol IH, Tayfun E, Harputluoglu M. Autoimmune haemolytic anemia and thrombocytopenia associated with ciprofloxacin. Clin Lab Haematol 1997; 19: 223
- Mourax A, Gille M, Pieret F, Declercq I. Fulminant thrombotic thrombocytopenic purpura in the course of ciprofloxacin therapy. Rev Neurol (Paris) 2002; 158: 1115–1117
- Starr JA, Ragucci KR. Thrombocytopenia associated with intravenous ciprofloxacin. Pharmacotherapy 2005; 25: 1030–1034
- Allan DS, Thomson CM, Barr RM, Clark WF, et al. Ciprofloxacin-associated haemolytic-uremic syndrome. Ann Pharmacother 2002; 36: 1000–1002
- Lim S, Alam MG. Ciprofloxacin-induced acute interstitial nephritis and autoimmune haemolytic anaemia. Ren Fail 2003; 25: 647–651
- Kundu K. Ciprofloxacin-induced severe cutaneous reaction and haemolysis in a young adult. J Assoc Physician India 2000; 48: 649–650
- Glynne P, Salama A, Chaudhry A, Swirsky D, et al. Quinine-induced immune thrombocytopenic purpura followed by hemolytic uremic syndrome. Am J Kidney Dis 1999; 33: 133–137
- Bougie DW, Wilker PR, Aster RH. Patients with quinine-induced immune thrombocytopenia have both “drug-dependent” and “drug specific” antibodies. Blood 2006; 108: 922–927